Bruker Introduces Innovative Neuroscience Research Solution with High-Speed OptoVolt Voltage Imaging
07 October 2024 - 10:00PM
Business Wire
New Multiphoton Microscopy Module Enables
Millisecond Neural Event Imaging at Single Neuron
Resolution
At the Neuroscience 2024 conference, Bruker Corporation (Nasdaq:
BRKR) today announced the release of the OptoVolt™
module to further expand the advanced neuroscience research
capabilities on Bruker’s Ultima multiphoton microscope
platform. OptoVolt accelerates imaging speeds to beyond 1000
frames per second for the capture of millisecond dynamics of
cell-to-cell neural communication. With the emergence of
fluorescent voltage indicators, researchers are excited to measure
neural activity with higher temporal resolution than traditional
fluorescent calcium indicators have allowed.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20241007485247/en/
OptoVolt enables fluorescent voltage
trace extraction. (Graphic: Business Wire)
The OptoVolt module uniquely addresses the challenges of
voltage imaging by providing a scanner technology that is capable
of operating at the ultrafast speeds and with the signal-to-noise
ratio required to detect individual neural events. Furthermore,
when combined with Bruker’s NeuraLight 3D Ultra® spatial
light modulator (SLM) for 3D optogenetic activation, the entire
platform enables researchers to probe input-output relationships of
neural ensembles at unprecedented temporal and spatial
resolutions.
“I see voltage imaging becoming a key tool in the investigation
of neural circuits and systems neuroscience in the near future,”
said Professor Thomas Clandinin, Department of Neurobiology at
Stanford University. “We are excited about new instrumentation that
expands the possibilities for optically interrogating cellular and
sub-cellular signaling at the temporal resolution of individual
action potentials.”
“We are proud to introduce this significant advancement in
neural circuit imaging capabilities, with its combined unparalleled
imaging speed and signal-to-noise performance that allows
millisecond neural event detection at single neuron resolution,”
added Xiaomei Li, Ph.D., Vice President and General Manager of
Bruker’s Fluorescence Microscopy Business. “OptoVolt
demonstrates how we pay attention to our customers’ evolving
research needs and work closely with them to drive innovation. With
such direct collaboration, we are able to build upon the versatile
Ultima 2Pplus platform as the ideal solution for all-optical
neuroscience research.”
About the OptoVolt Module
The OptoVolt module, integrates seamlessly with the
Ultima 2Pplus multiphoton microscope to provide
kilohertz-level imaging speeds, capturing dynamics at up to 1000
frames per second. OptoVolt technology leverages novel
voltage indicator proteins, such as ASAP4 from Stanford University
and JEDI-2P from Baylor University, ensuring compatibility with the
latest developments in the field. The system's modular design
retains the depth and resolution of traditional two-photon imaging,
while enabling flexible adjustments between speed and signal
intensity. Additionally, OptoVolt’s integration with the
NeuraLight 3D Ultra SLM allows for simultaneous optogenetic
manipulation and voltage imaging, facilitating comprehensive
functional mapping of neural circuits. This capability allows
researchers to visualize action potentials and sub-threshold
membrane potentials across large neural networks, bridging the gap
between single-cell electrophysiology and wide-field calcium
imaging.
About Bruker Corporation – Leader of the Post-Genomic Era
(Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough
post-genomic discoveries and develop new applications that improve
the quality of human life. Bruker’s high performance scientific
instruments and high value analytical and diagnostic solutions
enable scientists to explore life and materials at molecular,
cellular, and microscopic levels. In close cooperation with our
customers, Bruker is enabling innovation, improved productivity,
and customer success in post-genomic life science molecular and
cell biology research, in applied and biopharma applications, in
microscopy and nanoanalysis, as well as in industrial and cleantech
research, and next-gen semiconductor metrology in support of AI.
Bruker offers differentiated, high-value life science and
diagnostics systems and solutions in preclinical imaging, clinical
phenomics research, proteomics and multiomics, spatial and
single-cell biology, functional structural and condensate biology,
as well as in clinical microbiology and molecular diagnostics. For
more information, please visit www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241007485247/en/
Investor Contact: Joe Kostka Associate Director, Investor
Relations Bruker Corporation T: +1 (978) 313-5800 E:
Investor.Relations@bruker.com Media Contact: Stephen Hopkins
Content Marketing Manager Bruker Nano Surfaces and Metrology T: +1
(520) 741-1044 x1022 E: steve.hopkins@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Dec 2024 to Jan 2025
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jan 2024 to Jan 2025